Purple periwinkles may help fight inflammatory diseases
May 4th, 2010 - 12:53 pm ICT by ANIWashington, May 4 (ANI): Vinpocetine, a natural product derived from the periwinkle plant, can act as a novel anti-inflammatory agent that may one day be used for the treatment of chronic obstructive pulmonary disease, or COPD, as well as other inflammatory conditions, say scientists.
In the study published in the Proceedings of the National Academy of Sciences, researchers at the University of Rochester Medical Center were the first to find that vinpocetine acts as a potent anti-inflammatory agent when tested in a mouse model of lung inflammation, as well as several other types of human cells.
Results of the study show that vinpocetine greatly reduces inflammation, and, unlike steroids, does not cause severe side effects.
“What is extremely exciting and promising about these findings is vinpocetine’s excellent safety profile,” said Chen Yan, Ph.D., associate professor within the Aab Cardiovascular Research Institute at the Medical Center and a senior author of the study. “Previously, most drugs tested in this area have failed, not because of a lack of efficacy, but because of safety issues. We’re very encouraged by these results and believe vinpocetine has great potential for the treatment of COPD and other inflammatory diseases.”
Vinpocetine is a well-known natural product that was originally discovered nearly 30 years ago and is currently used as a dietary supplement for the prevention and treatment of cognitive disorders, such as stroke and memory loss, in Europe, Japan and China. (ANI)
- Diabetes drug can stave off leading cause of blindness - May 09, 2012
- Protein shows promise in treating smoker's diseases - Jan 16, 2012
- Finding paves way for new personalized treatments to target inflammation - Apr 05, 2011
- Tumeric derivative found promising in tendinitis - Aug 11, 2011
- Experimental non-steroidal treatment of asthma holds promise - Jul 02, 2010
- Cigarette smoke may cause inflammation through a new chemical pathway - Sep 03, 2010
- Four novel biomarkers that may help diagnose asthma, COPD identified - Mar 12, 2011
- Protein that may fight against inflammatory disease identified - Oct 21, 2010
- Anti-inflammatory drugs reduce effectiveness of antidepressants - Apr 26, 2011
- New therapeutic target for asthma, other lung disorders identified - Apr 18, 2011
- Ion channel responsible for pain discovered - Dec 18, 2010
- 'Master switch' for key immune cells in inflammatory diseases found - Jan 17, 2011
- New way to halt lung inflammation in animal models discovered - Jan 15, 2011
- Green peppers, chamomile tea may protect against inflammation - Jul 09, 2010
- New signaling pathway linked to inflammatory disease discovered - Dec 15, 2010
Tags: cardiovascular research institute, chronic obstructive pulmonary disease, cognitive disorders, inflammatory agent, inflammatory conditions, inflammatory diseases, lung inflammation, memory loss, national academy of sciences, obstructive pulmonary disease, periwinkle plant, proceedings of the national academy, proceedings of the national academy of sciences, purple periwinkles, rochester medical center, safety profile, types of human cells, university of rochester, university of rochester medical center, vinpocetine